The assessment of colour abnormalities has long been of interest in the evaluation of the patency ot the visual pathways. Kollner' attempted a classification of acquired colour vision defects according to their disease site: a defect in the media or receptors causes a blue/yellow defect (tritan), whereas dysfunction of the visual pathway from the ganglion cell layer to the cortex causes a more pronounced defect in red/green discrimination.
The clinical importance of the assessment of colour vision lies in (a) the susceptibility of the colour detecting system to early disease processes in the eye and its perceptual pathway, and (b) the fact that abnormal colour vision, when the abnormality is due to disease, often precedes and then parallels a decrease in visual acuity. Colour detection and interpretation relies on In some cases of glaucoma the visual acuity as measured on a Snellen chart may be normal though the peripheral field is restricted. Is it possible to measure any changes of central vision in these cases? An averaged spectral sensitivity for glaucoma patients with visual acuity of 6/9 (or better) is shown in Fig. 2c . Only a small decrease in sensitivity was noted for test spots greater than 500 nm (green to red spectral lights), but the test wavelengths less than 500 nm (blue region of spectrum) showed a sensitivity substantially less than normal.
In toxic amblyopia there is a moderate to severe loss of visual acuity with central scotoma. The visual disturbance caused by overconsumption of tobacco includes the classical loss of central vision for red. A large loss of long wavelength sensitivity along with an even greater loss of narrow-band short-wavelength sensitivity relative to normal was noted in the average spectral sensitivities for 10 eyes with tobacco amblyopia6 (Fig. 2d) .
Of particular interest to our Manchester group measuring acquired colour deficiencies with the spectral threshold technique are diseases which affect the optic nerve. The results of our measurements on 3 eyes with DIDMOAD (diabetes insipidus, diabetes mellitus, optic atrophy, and nerve deafness) syndrome and 10 eyes in a family of late-onset, dominant, hereditary optic atrophy are averaged in Figs. 2e and 2f. These patients had little or no colour vision with the Famsworth-Munsell 100-hue test, and their visual acuity ranged from 6/12 to 6/36. These results have previously been interpreted as a loss of tonic ganglion cells,57 and the observed spectral sensitivity for 0 5-second flashes-i.e., a smooth single curve peaking at 555 nm instead of the normal 3-peak coiaur opponent curve-is thought to be due to a sparing of the other major class of retinal ganglion cells, namely, phasic cells.
Electrophysiological research8 on the phasic ganglion has shown a primarily noncolour opponent system that responds well to fast flicker and has a single peak of spectral sensitivity at 555 nm. Flickering the test spot at 25 Hz (the spectral flicker sensitivity test), we can predict the detection of the flicker that would be accomplished by the phasic ganglion cells in the normal eye. The spectral flicker sensitivity in our procedure yielded a single peak sensitivity at 550 nm in the normal eye (dashed curve, Fig. 3a ). An average of 10 eyes with optic atrophy (Fig. 3b) showed their spectral flicker sensitivity to be very similar to normal in both amplitude and shape.
In some cases of retrobulbar neuritis (RBN) a decrease in the critical fusion frequency (CFF) has been observed.9 The spectral threshold (1 Hz) for eyes recovering from RBN showed a decrease in sensitivity, especially in the blue range (<500 nm), in our test on a white background. The spectral sensitivity for 25 Hz flicker of the RBN patients is an example of severe loss of flicker sensitivity (Fig. 3c) , while the detection of 0-5-second flashes (e.g., at about 550 nm) is nearly normal.6
Discussion
The results of the diseased eyes for 0-5-second flashes may be divided into 2 categories: the region of the spectral sensitivity curve less than 500 nm (referred to as 'blue') and the curve in the region greater than 500 nm ('green/red'). This division is convenient for relating the results to the subclassification of tonic opponent-colour ganglion cells categorised as red/ green and blue/yellow.4 In all the above diseases a loss in the blue sensitivity is noted. This correlates with the findings of other workers2 "l I that the blue mechanism seems vulnerable early in the course of many eye disorders.
In the red/green region 2 systems are contributing to the spectral threshold-the colour opponent tonic ganglion cells and the phasic ganglion cells. In cases of generalised sensitivity loss-that is, when the curve for detection of 0O5-second flashes retains a normal shape-the loss may be due to nonspecific damage of all types of optic nerve fibres. After a specific loss of the red/green tonic cells we might predict a change in the shape of the spectral threshold, so that the 2 peaks near 520 nm and 600 nm would be replaced by a single peak at 555 nm (phasic cell peak sensitivity). KingSmith and others have interpreted the spectral sensitivities of patients with optic atrophy in terms of this selective damage to tonic cells.57 The loss of red/green sensitivity for the 0O5-second flashes seems to correspond well with acuity loss, while loss of only blue sensitivity seems to precede a measureable loss in central visual acuity.
Damage to the phasic cell system can be seen in the reduced sensitivity to the spectral flicker sensitivity at 25 Hz. In cases of retrobulbar neuritis (Fig. 3c) 
